Adamis Pharmaceuticals reported 0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Adamis Pharmaceuticals ADMP:US 0 0
Adma Biologics ADMA:US $ 138.42M 43.56M
Brainstorm Cell Therapeutics BCLI:US $ 0M 0M
Cara Therapeutics CARA:US $ 0 0
Cerulean Pharma CERU:US $ 0 0
Glaxosmithkline GSK:US $ 18784M 10442M
GlaxoSmithKline GSK:LN 18784M 10442M
Redhill Biopharma RDHL:US $ 93.58M 7.39M